Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell Responses: Molecular Therapy
PDF) RNA Vaccines in Cancer Treatment
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
S. Heine, Ann-Kristin Hedmark & Bosse Broberg - Wanderer | Play on Anghami
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
UKB NewsRoom | Auszeichnung für herausragende Krebsforscher + + + mehr:
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
IJMS | Free Full-Text | The Relevance of G-Quadruplexes for DNA Repair
Interplay of Guanine Oxidation and G-Quadruplex Folding in Gene Promoters | Journal of the American Chemical Society
Volume 21, Issue 3, Pages (October 2017) - ppt download
Team | IMMEI
Implementing combinatorial immunotherapeutic regimens against cancer
UKB NewsRoom | Annkristin Heine
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
Immunotherapy as an advance in cancer medicine - Innovations Report
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
